ORAMED PHARMACEUTICALS INC.

PublicCIK: 1176309
ORMPNASDAQ
Location

NEW YORK, NY

ORAMED PHARMACEUTICALS INC. enters LIFEWARD LTD. with 1.25M shares plus derivative instruments

Holding both equity and derivatives at entry signals strong long-term conviction in the company.

Direct Derivatives
InsiderORAMED PHARMACEUTICALS INC.CIK 1176309
IssuerLIFEWARD LTD.CIK 1607962
10% Owner
Since Mar 2026
1.25M
Baseline shares
100% direct
1.25M
Direct ownership
1 position
5.64M
Derivative underlying
4 instruments
1
Security positions
All direct
Non-Derivative Holdings1

Ordinary Shares

Direct
Shares owned1.25M
Total
1.25M direct1.25M
Derivative Holdings4

Senior Secured Convertible Notes

Direct
Underlying security
Ordinary Shares

Underlying shares

1.67M

Shares owned

N/A

Exercise price

5.40

Expiration

Exercise window

Warrants (right to buy)

Direct
Underlying security
Ordinary Shares

Underlying shares

1.67M

Shares owned

N/A

Exercise price

5.40

Expiration

Exercise window

Warrants (right to buy)

Direct
Underlying security
Ordinary Shares

Underlying shares

1.30M

Shares owned

N/A

Exercise price

5.40

Expiration

Exercise window

Warrants (right to buy)

Direct
Underlying security
Ordinary Shares

Underlying shares

1.01M

Shares owned

N/A

Exercise price

0

Expiration

Exercise window

Total

Underlying

5.64M

Owned

0.00

ORAMED PHARMACEUTICALS INC. — Initial Ownership Disclosure (Form 3) Filed May 14, 2026 | Finecho